Ramelteon(melatonin receptor agonist)for neuromuscular degenerative disease and neuroimmunological disease;examination for safety
Not Applicable
- Conditions
- neuromuscular degenerative disease and neuroimmunological disease
- Registration Number
- JPRN-UMIN000006298
- Lead Sponsor
- Yokohama city University Graduate School of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
As a rule ,these patients are excluded; patients whose %VC are 50% or less,patients who has respiratory disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o significant difference on ODI3 before and after Ramelteon administration.
- Secondary Outcome Measures
Name Time Method Ramelteon utility should be proven by sleep score.